Remo H.M. Furtado

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Alexandre Biasi Cavalcanti, Fernando G Zampieri, Régis Goulart Rosa et al. · New England Journal of Medicine · 2020 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

Eri Kato, Michael G. Silverman, Ofri Mosenzon et al. · Circulation · 2019 · 563 citations

Medicine, Cardiology, Pharmacology +15

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Renato D. Lópes, Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado et al. · The Lancet · 2021 · 496 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus

Thomas A. Zelniker, Marc P. Bonaca, Remo H.M. Furtado et al. · Circulation · 2020 · 452 citations · Full text

Medicine, Cardiology, Pharmacology +17

Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial

Remo H.M. Furtado, Otávio Berwanger, Henrique Fonseca et al. · The Lancet · 2020 · 372 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9